Analysts who follow Arcturus Therapeutics Holdings Inc (ARCT) on average expect it to add 89.03% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns ARCT an Analyst Ranking of 71, which means it ranks higher than 71 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
Investors Observer combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Arcturus Therapeutics Holdings Inc Stock Today?
Arcturus Therapeutics Holdings Inc (ARCT) stock is lower by -2.21% while the S&P 500 is higher by 0.67% as of 2:26 PM on Thursday, Sep 24. ARCT is lower by -$0.86 from the previous closing price of $38.95 on volume of 436,795 shares. Over the past year the S&P 500 is higher by 9.17% while ARCT is higher by 194.36%. ARCT lost -$2.87 per share the over the last 12 months.